Pharmacological Abortion in a Pandemic: An Italian Medico-Legal Perspective

被引:2
|
作者
Cestonaro, Clara [1 ]
Aprile, Anna [1 ]
Bolcato, Matteo [1 ]
Rodriguez, Daniele [1 ]
Feola, Alessandro [2 ]
Di Mizio, Giulio [3 ]
机构
[1] Univ Padua, Legal Med, I-35121 Padua, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Expt Med, Via Luciano Armanni 5, I-80138 Naples, Italy
[3] Magna Graecia Univ Catanzaro, Dept Law, Forens Med, I-88100 Catanzaro, Italy
关键词
abortion; RU486; mifepristone; pandemic; COVID-19; legal medicine; MIFEPRISTONE;
D O I
10.3390/ijerph182212043
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The limitations caused by the spread of the SARS-CoV2 virus have had repercussions on the voluntary termination of pregnancy. During the pandemic, Italy issued updated guidelines regarding voluntary termination of pregnancy by means of mifepristone and prostaglandin. This included news concerning the time limit and location in which this procedure could be accessed: updates partially recognize women's needs, and they are into line with the European parliament's recent exhortations. However, these updates do not change the previously provided responsibilities that lie with doctors. This article aimed to compare regulations concerning medical abortion in Italy and other countries, with a focus on recent Italian updates in the context of pandemic.
引用
收藏
页数:10
相关论文
共 50 条